SC 13G/A: Profound Medical Corp.

AI Summary

SC 13G/A filing by Profound Medical Corp..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• c109624_sc13ga.htm (SC 13G/A) — 56KB
• 0000930413-24-002249.txt ( ) — 58KB

From the Filing

SC 13G/A 1 c109624_sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Profound Medical Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 74319B502 (CUSIP Number) July 31, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 74319B502 13G Page 2 of 7 1. Names Of Reporting Persons BDC Capital Inc. 2. check the appropriate box if a group (a) (b) 3. sec use only 4. citizenship or place of organization Canadian number of shares beneficially owned by each reporting person with: 5. sole voting power 0 6. shared voting power 1,223,480 7. sole dispositive power 1,223,480 8. shared dispositive power 0 9. aggregate amount beneficially owned by each reporting person 1,223,480 10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o 11. percent of class represented by amount in row (9) 4.998% 12. type of reporting person (See Instructions) CO CUSIP No. 74319B502 13G Page 3 of 7 1. Names Of Reporting Persons Amplitude Venture Capital Management Inc. 2. check the appropriate box if a group (a) (b) 3. sec use only 4. citizenship or place of organization Canadian number of shares beneficially owned by each reporting person with: 5. sole voting power 0 6. shared voting power 1,223,480 7. sole dispositive power 0 8. shared dispositive power 0 9. aggregate amount beneficially owned by each reporting person 1,223,480 10. check box if the aggregate amount in row (9) excludes certain shares (See Instructions) o 11. percent of class represented by amount in row (9) 4.998% 12. type of reporting person (See Instructions) IA CUSIP No. 74319B502 13G Page 4 of 7 Item 1. (a) Name of Issuer: Profound Medical Corp. (b) Address of Issuer’s Principal 2400 Skymark Avenue, Unit 6 Executive Offices: Mississauga, Ontario L4W 5K5 Item 2. (a) Name of Person Filing: BDC Capital Inc. is a Crown corporation whose sole shareholder is the Government of Canada. Amplitude Venture Capital Management Inc. serve as BDC Capital’s investment adviser. (b) Address of Principal Business Office 5 Place Ville Marie, Suite 100 Montreal, Quebec, Canada H3B 5E7 or, if none, Residence: (c) Citizenship: Canadian (d) Title of Class of Securities: Common Shares (e) CUSIP Number: 74319B502 CUSIP No. 74319B502 13G Page 5 of 7 Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) o A parent holding company or control person in accordance with § 13d-1(b)(1)(ii)(G); (h) o A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15U.S.C. 80a-3); (j) o A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 74319B502 13G Page 6 of 7 Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,223,480 (b) Percent of class: 4

View Full Filing

View this SC 13G/A filing on SEC EDGAR